ICON Share Holder Equity 2010-2024 | ICLR

ICON share holder equity from 2010 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
  • ICON share holder equity for the quarter ending September 30, 2024 was $9.774B, a 9.1% increase year-over-year.
  • ICON share holder equity for 2023 was $9.241B, a 8.74% increase from 2022.
  • ICON share holder equity for 2022 was $8.498B, a 5.34% increase from 2021.
  • ICON share holder equity for 2021 was $8.067B, a 335.99% increase from 2020.
ICON Annual Share Holder Equity
(Millions of US $)
2023 $9,241
2022 $8,498
2021 $8,067
2020 $1,850
2019 $1,658
2018 $1,354
2017 $1,191
2016 $945
2015 $763
2014 $950
2013 $911
2012 $755
2011 $682
2010 $670
2009 $572
ICON Quarterly Share Holder Equity
(Millions of US $)
2024-09-30 $9,774
2024-06-30 $9,585
2024-03-31 $9,433
2023-12-31 $9,241
2023-09-30 $8,959
2023-06-30 $8,796
2023-03-31 $8,654
2022-12-31 $8,498
2022-09-30 $8,239
2022-06-30 $8,146
2022-03-31 $8,069
2021-12-31 $8,067
2021-09-30 $7,969
2021-06-30 $2,028
2021-03-31 $1,934
2020-12-31 $1,850
2020-09-30 $1,711
2020-06-30 $1,578
2020-03-31 $1,514
2019-12-31 $1,658
2019-09-30 $1,537
2019-06-30 $1,529
2019-03-31 $1,422
2018-12-31 $1,354
2018-09-30 $1,334
2018-06-30 $1,239
2018-03-31 $1,205
2017-12-31 $1,191
2017-09-30 $1,128
2017-06-30 $1,030
2017-03-31 $945
2016-12-31 $945
2016-09-30 $992
2016-06-30 $910
2016-03-31 $844
2015-12-31 $763
2015-09-30 $863
2015-06-30 $1,022
2015-03-31 $999
2014-12-31 $950
2014-09-30 $1,011
2014-06-30 $998
2014-03-31 $961
2013-12-31 $911
2013-09-30 $855
2013-06-30 $802
2013-03-31 $768
2012-12-31 $755
2012-09-30 $719
2012-06-30 $684
2012-03-31 $702
2011-12-31 $682
2011-09-30 $697
2011-06-30 $712
2011-03-31 $693
2010-12-31 $670
2010-09-30 $647
2010-06-30 $598
2010-03-31 $585
2009-12-31 $572
2009-09-30 $541
2009-06-30 $508
2009-03-31 $474
Sector Industry Market Cap Revenue
Medical Medical Services $18.679B $8.120B
ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Charles River Laboratories (CRL) United States $9.742B 18.41
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00